Patent Expiration Date : 2024-07-06
US Patent Number : 7176211
Drug Substance Claim :
Drug Product Claim :
Application Number : 210450
Patent Use Code : U-2360
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2024-07-06
Patent Expiration Date : 2029-07-06
US Patent Number : 7419983
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 210450
Patent Use Code : U-2360
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2029-07-06
Patent Expiration Date : 2024-07-06
US Patent Number : 7176211
Drug Substance Claim :
Drug Product Claim :
Application Number : 210450
Patent Use Code : U-2360
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2024-07-06
Patent Expiration Date : 2029-07-06
US Patent Number : 7419983
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 210450
Patent Use Code : U-2360
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2029-07-06
Patent Expiration Date : 2036-09-01
US Patent Number : 10537572
Drug Substance Claim :
Drug Product Claim :
Application Number : 210450
Patent Use Code : U-2735
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2036-09-01
Patent Expiration Date : 2036-09-01
US Patent Number : 10682351
Drug Substance Claim :
Drug Product Claim :
Application Number : 210450
Patent Use Code : U-2850
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2036-09-01
Patent Expiration Date : 2028-11-07
ELAGOLIX SODIUM,ESTRADIOL,NORETHINDRONE ACETATE; ELAGOLIX SODIUM
US Patent Number : 11459305
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 213388
Patent Use Code : U-2842
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2028-11-07
Patent Expiration Date : 2034-03-14
US Patent Number : 11344551
Drug Substance Claim :
Drug Product Claim :
Application Number : 210450
Patent Use Code : U-3388
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2034-03-14
Patent Expiration Date : 2034-03-14
US Patent Number : 11344551
Drug Substance Claim :
Drug Product Claim :
Application Number : 210450
Patent Use Code : U-3389
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2034-03-14
Patent Expiration Date : 2034-03-14
ELAGOLIX SODIUM,ESTRADIOL,NORETHINDRONE ACETATE; ELAGOLIX SODIUM
US Patent Number : 10881659
Drug Substance Claim :
Drug Product Claim :
Application Number : 213388
Patent Use Code : U-2842
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2034-03-14
LOOKING FOR A SUPPLIER?
Market Place
